AR094035A1 - Estimulantes del colageno y su uso en el tratamiento de la piel - Google Patents
Estimulantes del colageno y su uso en el tratamiento de la pielInfo
- Publication number
- AR094035A1 AR094035A1 ARP130104765A ARP130104765A AR094035A1 AR 094035 A1 AR094035 A1 AR 094035A1 AR P130104765 A ARP130104765 A AR P130104765A AR P130104765 A ARP130104765 A AR P130104765A AR 094035 A1 AR094035 A1 AR 094035A1
- Authority
- AR
- Argentina
- Prior art keywords
- collagen
- skin
- skin treatment
- production
- cosmetically acceptable
- Prior art date
Links
- 102000008186 Collagen Human genes 0.000 title abstract 3
- 108010035532 Collagen Proteins 0.000 title abstract 3
- 229920001436 collagen Polymers 0.000 title abstract 3
- 239000000021 stimulant Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
Abstract
Se proveen métodos para evitar, o reducir los signos dermatológicos del envejecimiento que emplean una composición cosmética que comprende agentes activos que mejoran la producción de colágeno en la piel. Reivindicación 15: Un método para mejorar la producción de colágeno en la piel humana que comprende aplicar tópicamente a un área de la piel que lo necesita una composición tópica que comprende un vehículo cosméticamente aceptable y una cantidad eficaz de un compuesto que tiene la estructura de fórmula (1) y sus sales cosméticamente aceptables. Reivindicación 16: El método conforme con la reivindicación 15, en donde dicha composición además comprende un retinoide. Reivindicación 17: El método conforme con la reivindicación 15, en donde dicha composición además comprende ácido glicólico y/o ácido salicílico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/721,509 US8865700B2 (en) | 2012-12-20 | 2012-12-20 | Collagen stimulators and their use in the treatment of skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR094035A1 true AR094035A1 (es) | 2015-07-08 |
Family
ID=50975307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130104765A AR094035A1 (es) | 2012-12-20 | 2013-12-16 | Estimulantes del colageno y su uso en el tratamiento de la piel |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8865700B2 (es) |
| AR (1) | AR094035A1 (es) |
| TW (1) | TW201424765A (es) |
| WO (1) | WO2014099115A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3915367A1 (en) | 2010-08-18 | 2021-12-01 | BioSplice Therapeutics, Inc. | Diketones and hydroxyketones as catenin signaling pathway activators |
| US8901122B2 (en) | 2012-12-20 | 2014-12-02 | Avon Products, Inc. | Collagen stimulators and their use in the treatment of skin |
| HRP20190142T1 (hr) | 2013-02-22 | 2019-03-22 | Samumed, Llc | Gama-diketoni kao aktivatori signalizacijskog puta wnt/beta-katenina |
| BR112017003959B1 (pt) | 2014-08-20 | 2022-08-02 | Samumed, Llc | Uso de um composto de fórmula i ou um sal dermatologicamente aceitável do mesmo |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6159485A (en) | 1999-01-08 | 2000-12-12 | Yugenic Limited Partnership | N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use |
| EP1359885A4 (en) | 2001-01-25 | 2005-03-16 | Gen Hospital Corp | NOS-HEMMER FOR THE TREATMENT OF WRINKLES |
| US20030045449A1 (en) | 2001-08-15 | 2003-03-06 | Pfizer, Inc. | Pharmaceutical combinations for the treatment of neurodegenerative diseases |
| PL370324A1 (en) | 2001-11-09 | 2005-05-16 | Aventis Pharma S.A. | 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| US7320797B2 (en) | 2003-08-29 | 2008-01-22 | Bioderm Research | Antiaging cosmetic delivery systems |
-
2012
- 2012-12-20 US US13/721,509 patent/US8865700B2/en active Active
-
2013
- 2013-10-15 WO PCT/US2013/064917 patent/WO2014099115A1/en not_active Ceased
- 2013-10-17 TW TW102137580A patent/TW201424765A/zh unknown
- 2013-12-16 AR ARP130104765A patent/AR094035A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201424765A (zh) | 2014-07-01 |
| WO2014099115A1 (en) | 2014-06-26 |
| US8865700B2 (en) | 2014-10-21 |
| US20140179642A1 (en) | 2014-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201890218A1 (ru) | Ретиноидные композиции для местного применения | |
| MX2021009652A (es) | Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel. | |
| MX386820B (es) | Microcápsulas lipídicas que comprenden de preferencia un retinoide y composición que las contiene, su procedimiento de preparación y su uso en dermatología. | |
| BRPI1106572B8 (pt) | Composições que compreendem um retinoide e um inibidor de nfkb e seus métodos de uso | |
| AR081789A1 (es) | Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel | |
| MX390974B (es) | Uso cosmético o dermatológico de naringenina para combatir efectos de envejecimiento de la piel. | |
| BR112014026056A2 (pt) | compostos, kits e métodos de biofotônica | |
| BR112015021616A2 (pt) | materiais biofotônicos e utilizações dos mesmos | |
| ES2543957T3 (es) | Nueva composición farmacéutica para el tratamiento de infecciones fúngicas | |
| CO6460708A2 (es) | Composiciones borínicas | |
| CL2016000544A1 (es) | Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel. | |
| BR112015026388A2 (pt) | métodos e composições para cicatrização de feridas | |
| BR112014012941A2 (pt) | Composição para cuidado pessoal, método cosmético para tratar pele, e, métodos para inibir a degradação de colágeno na pele e para reduzir os sinais visíveis de envelhecimento | |
| MX2018016108A (es) | Metodo para el cuidado de la piel. | |
| AR094035A1 (es) | Estimulantes del colageno y su uso en el tratamiento de la piel | |
| ECSP21075003A (es) | Composición cosmética tópica y usos de la misma | |
| BR112015027436A8 (pt) | composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos | |
| MX2018007191A (es) | Composicion para beneficiar la piel a base de un solvente hidroxi funcionalizado. | |
| PH12018500910A1 (en) | Novel method of use and compositions | |
| AR084197A1 (es) | Composicion para uso topico para el tratamiento de trastornos de la piel | |
| MX363850B (es) | Composicion cosmetica o dermatologica que comprende una merocianina, una fase aceitosa y un monoalcanol c1-c4. | |
| AR097216A1 (es) | Composición para el tratamiento contra el envejecimiento de la piel | |
| MX374618B (es) | Ésteres sulfatados de ácidos oligohidroxicarboxílicos, y uso de los mismos. | |
| CL2018003858A1 (es) | Composicion para el cuidado de la piel y uso de la misma. | |
| AR094033A1 (es) | Composicion cosmetica para mejorar la apariencia estetica de la piel humana |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |